Axsome Therapeutics, Inc. financial statements
Axsome Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 638.5M | 10-K |
| Net income | −USD 183.17M | 10-K |
| Cash and equivalents | USD 322.93M | 10-Q |
| Total debt | USD 187.75M | 10-Q |
Axsome Therapeutics, Inc. financials on 6ix · Axsome Therapeutics, Inc. on 6ix